[go: up one dir, main page]

AU2001235364A1 - Tetrahydronaphtalene derivatives and their use - Google Patents

Tetrahydronaphtalene derivatives and their use

Info

Publication number
AU2001235364A1
AU2001235364A1 AU2001235364A AU3536401A AU2001235364A1 AU 2001235364 A1 AU2001235364 A1 AU 2001235364A1 AU 2001235364 A AU2001235364 A AU 2001235364A AU 3536401 A AU3536401 A AU 3536401A AU 2001235364 A1 AU2001235364 A1 AU 2001235364A1
Authority
AU
Australia
Prior art keywords
tetrahydronaphtalene
derivatives
tetrahydronaphtalene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235364A
Inventor
John Bondo Hansen
Ming Li
Tina Moller Tagmose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
University of South Alabama
Original Assignee
Novo Nordisk AS
University of South Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, University of South Alabama filed Critical Novo Nordisk AS
Publication of AU2001235364A1 publication Critical patent/AU2001235364A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001235364A 2000-02-25 2001-02-23 Tetrahydronaphtalene derivatives and their use Abandoned AU2001235364A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200000294 2000-02-25
DKPA200000294 2000-02-25
US18529400P 2000-02-28 2000-02-28
US60185294 2000-02-28
PCT/DK2001/000129 WO2001062741A1 (en) 2000-02-25 2001-02-23 Tetrahydronaphtalene derivatives and their use

Publications (1)

Publication Number Publication Date
AU2001235364A1 true AU2001235364A1 (en) 2001-09-03

Family

ID=26068778

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235364A Abandoned AU2001235364A1 (en) 2000-02-25 2001-02-23 Tetrahydronaphtalene derivatives and their use

Country Status (3)

Country Link
US (1) US6410743B2 (en)
AU (1) AU2001235364A1 (en)
WO (1) WO2001062741A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1581558A2 (en) * 2003-01-07 2005-10-05 Neuromed Technologies, Inc. Fluorescence based t-type channel assay
US20080089947A1 (en) * 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia
JP2012506415A (en) * 2008-10-22 2012-03-15 アクテリオン ファーマシューティカルズ リミテッド Crosslinked tetrahydronaphthalene derivatives
US8575361B2 (en) 2010-03-02 2013-11-05 Concert Pharmaceuticals Inc. Tetrahydronaphthalene derivatives
WO2011109464A1 (en) * 2010-03-02 2011-09-09 Concert Pharmaceuticals Inc. Deuterated tetrahydronaphthalene derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1319144C (en) * 1986-11-14 1993-06-15 Quirico Branca Tetrahydronaphthalene derivatives
US4808650A (en) 1988-03-14 1989-02-28 Becton, Dickinson And Company High clarity polyolefin compositions and clarifying additive therein
US5712392A (en) * 1990-12-28 1998-01-27 Neurogen Corporation Certain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
CA2678722C (en) * 1998-07-10 2013-08-27 Novartis Ag Antihypertensive combination of valsartan and a calcium channel blocker
EP1108068A4 (en) * 1998-08-26 2002-12-04 Univ South Alabama T-TYPE CALCIUM CHANNEL

Also Published As

Publication number Publication date
WO2001062741A1 (en) 2001-08-30
US20010041730A1 (en) 2001-11-15
US6410743B2 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
AU3620600A (en) Skin-marking devices and their use
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002359126A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
HUP0203961A3 (en) 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes
AU2002359123A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002211717A1 (en) Stresscopins and their uses
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
AU2001289758A1 (en) Novel indole derivatives and their use as medicaments
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001230355A1 (en) Benzoxazole derivatives and their use as pesticides
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2001277561A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AU2001261375A1 (en) Human caspase-12 materials and methods
AU4432001A (en) Trityl-type compounds and their use
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU2669201A (en) Taccalonolides and their use
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2001262928A1 (en) Pharmaceutical compositions and their use